Terlipressin-Induced Ischemic Complications: A Systematic Review of Published Case Reports

ABSTRACT

Terlipressin is used in the management of variceal bleeding and hepatorenal syndrome. Ischemic complications are rare, but serious adverse effects of terlipressin therapy can be fatal. In this context, we reviewed all the published case reports of terlipressin-induced ischemic complications, and data were collected regarding the part of body affected by ischemic complication, latency, geographical variation, different treatment strategies and their outcome, and other relevant information. After an exhaustive search in different databases, 33 published cases were found. The ischemic complications affected virtually every part of the body. Peripheral gangrene was the most common ischemic complication followed by ischemic complications of more proximal parts such as thigh and abdominal wall. Other parts affected were heart, colon, small intestine, scrotum, etc. Most cases were managed conservatively. Although in few cases, other treatment options were also explored, knowledge of this dreaded complication and different management strategies is necessary for early identification of this adverse effect and early management so as to prevent fatality.

KEYWORDS

• Gangrene
• hepatorenal syndrome
• ischemic complication
• terlipressin
• vericeal bleeding

Showing references and in-text citations exactly as published.

Cite this article

• DOI10.4103/jpp.JPP_23_18Copy

RELATED ARTICLES

Matched on section and article type within this issue of J Pharmacol. Pharmacother..

• Review · VOLUME 9, ISSUE 2Comprehensive Review on Methadone-Induced QT Prolongation and TorsadesJennifer M Treece, Mohammad Madani, George Khoury, Ola Khraisha, James E Martin, Steven J Baumrucker, Christopher A Neglia, Timir K Paul · pp. 66–75Review ArticleSame type: Review